Hear Dr. Eyal Muscal from Baylor College of Medicine speak about the ability to detect changes in the brains of children with lupus that may appear normal with the use of conventional brain imaging methods. Topics: lupus research, CNS, NPSLE
Investigators discovered that high levels of osteopontin, a protein in the blood, may be a predictor of future disease activity and organ damage in both adults and children with lupus. This biomarker could help physicians determine a proper course of therapy much earlier. Listen to the podcast to learn more Topics: lupus research, biomarker, organ damage
Hear Dr. Kenneth Kalunian from UCSD speak about LFA's Collective Data Analysis Initiative (CDAI), which was launched so we can learn about the impacts that background therapies may have had on lupus clinical trial outcomes and use that knowledge to improve the design of future trials of potential new therapies for lupus. Topics: lupus research, treatment, drug development
Hear JHU's Dr. Michelle Petri speak about the Systemic Lupus International Collaborating Clinic's (SLICC) revision of the American College of Rheumatology (ACR) SLE classification criteria and validation of the new criteria in order to improve clinical relevance, meet more stringent methodology requirements and incorporate new knowledge in SLE immunology. Topics: diagnosing lupus, lupus research, new criteria
The Lupus Foundation of America's Michael Jon Barlin Pediatric Lupus Research Program provides funding to facilitate research related to childhood lupus. Dr. Hermine Brunner, Professor of Pediatrics at the Cincinnati Children's Hospital, has received funding from the Lupus Foundation of America to conduct research on health-related quality of life in children and adolescents with lupus. In this podcast, she discusses her research in this important area. Topics: pediatric lupus, cSLE, HRQOL, health related quality of life, lupus research, lupus foundation of...
Vikki Abrahams, PhD, Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine, discusses data from her study that was supported by the Lupus Foundation of America national lupus research program. The study looked at the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome. Topics: lupus, SLE, antiphospholipid antibodies, APS, lupus foundation of america, lupus research
byLupus Foundation of America, Inc. National Office
Theresa Lawrence Ford, M.D., Medical Director, North Georgia Rheumatology Group Lawrenceville, Georgia discusses the EMBODY Program, a Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical study of the efficacy and safety of the investigational drug epratuzumab for the potential treatment of Systemic Lupus Erythematosus in people with moderate to severe disease. Topics: lupus, systemic lupus erythematosus, SLE, embody, epratuzumab, clinical study, lupus treatment,...